16.08.2023 | REVIEW ARTICLE
Biologic drugs in the treatment of juvenile dermatomyositis: a literature review
Erschienen in: Clinical Rheumatology | Ausgabe 2/2024
Einloggen, um Zugang zu erhaltenAbstract
Key Points • There is no consensus on the choice and efficacy of biologic therapies in JDM. • RTX and TNF inhibitors are the most commonly used biologic drugs. • Biologics were especially preferred in severe skin involvement, calcinosis, and resistant diseases. |